Home Biosimilar Antibodies Immunology & Inflammation Interleukins antibody Sapelizumab (Anti-IL-6Ra / CD126) For research use only.
Not for use in humans.

Sapelizumab (Anti-IL-6Ra / CD126)

Synonyms: Satralizumab

Sapelizumab (Anti-IL-6Ra / CD126) is a human monoclonal antibody targeting IL-6. It is used for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease. MW :144.26 KD.

Sapelizumab (Anti-IL-6Ra / CD126)

Purity & Quality Control

≥99

Choose Selective Interleukins Inhibitors

Biological Activity

Description Sapelizumab (Anti-IL-6Ra / CD126) is a human monoclonal antibody targeting IL-6. It is used for the treatment of neuromyelitis optica spectrum disorder (NMOSD), a rare autoimmune disease. MW :144.26 KD.

Product Details

CAS No. 1535963-91-7
Molecular Weight 144.26
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Sapelizumab (Anti-IL-6Ra / CD126) | Sapelizumab (Anti-IL-6Ra / CD126) supplier | purchase Sapelizumab (Anti-IL-6Ra / CD126) | Sapelizumab (Anti-IL-6Ra / CD126) cost | Sapelizumab (Anti-IL-6Ra / CD126) manufacturer | order Sapelizumab (Anti-IL-6Ra / CD126) | Sapelizumab (Anti-IL-6Ra / CD126) distributor